Literature DB >> 22706530

Orbital MALT lymphoma, abdominal hodgkin lymphoma, and systemic diffuse large B-cell lymphoma develop sequentially in one patient.

Toshihiko Matsuo1, Kouichi Ichimura, Katsuji Shinagawa.   

Abstract

In February 2002, a 42-year-old woman developed ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT), MALT lymphoma, in the bilateral orbits involving lacrimal glands. She underwent 30 Gy external beam irradiation to the orbital lesions on both sides. She was well until November 2008 when she developed abdominal lymphadenopathy and transabdominal excisional biopsy showed mixed cellularity classical Hodgkin lymphoma at stage II. She underwent standard combination chemotherapy. In July 2010, she developed systemic lymphadenopathy and was diagnosed with diffuse large B-cell lymphoma (DLBCL) by cervical lymph node biopsy. She underwent rituximab monotherapy and finally allogeneic hematopoietic stem cell transplantation in October 2010, but died of renal failure in February 2011. Amplification by polymerase chain reaction of the immunoglobulin heavy chain gene gave rise to dominant discrete fragments of the same size between the orbital lesion with MALT lymphoma in 2002 and the cervical lymph node lesion with DLBCL in 2010. The sequential development of MALT lymphoma, Hodgkin lymphoma, and DLBCL in the long-term course of this patient suggests the common origin of the neoplastic cells, changing their pathological faces in response to irradiation and combination chemotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 22706530     DOI: 10.3960/jslrt.52.41

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  3 in total

1.  Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.

Authors:  Xubo Yang; Xiaoxue Min; Weimin He
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

2.  Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Yasuharu Sato; Hitomi Kataoka; Mayu Uka; Daisuke Ennishi; Tomofumi Yano
Journal:  J Clin Exp Hematop       Date:  2021

Review 3.  Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Kenji Notohara; Kazuya Okada
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.